Status:
COMPLETED
A Prognostic Tool for Early Stage CLL
Lead Sponsor:
Oncology Institute of Southern Switzerland
Collaborating Sponsors:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Chronic Lymphocytic Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The study aims at developing a model for the prediction of time to first treatment in chronic lymphocytic leukemia patients presenting with asymptomatic early stage disease
Detailed Description
Already existing and coded health-related personal data will be retrospectively collected from the CLL databases of the Institute of Oncology Research and of the Division of Hematology of the Universi...
Eligibility Criteria
Inclusion
- Male or female adults 18 years or older
- Diagnosis of chronic lymphocytic leukemia
- Binet A stage at presentation
- No treatment need at presentation
- Availability of the baseline and follow-up annotations
Exclusion
- None.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
4933 Patients enrolled
Trial Details
Trial ID
NCT03436524
Start Date
March 1 2018
End Date
February 28 2020
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria Maggiore della Carità
Novara, Italy, 28100